Literature DB >> 22584695

Anastomotic leak is not associated with oncologic outcome in patients undergoing low anterior resection for rectal cancer.

James D Smith1, Philip B Paty, José G Guillem, Larissa K Temple, Martin R Weiser, Garrett M Nash.   

Abstract

OBJECTIVE: To examine the association between anastomotic leak and oncologic outcome after anterior resection, stratifying for defunctioning stoma.
BACKGROUND: It has been hypothesized that anastomotic leak predisposes rectal cancer patients to local recurrence. Many have a defunctioning stoma to reduce risk of clinically significant leakage.
METHODS: The records of patients undergoing low anterior resection (1991-2010) for rectal adenocarcinoma (≤15 cm from anal verge) were retrospectively analyzed using a prospectively collected colorectal database. Data (age, gender, stage, defunctioning stoma, neoadjuvant treatment, distance from anal verge, anastomotic leak) were collected. Clinical leakage was defined as anastomotic complication requiring intervention or interventional radiology within 60 days of surgery. Estimated local recurrence, overall survival, and disease-specific survival were compared using log-rank method and Cox regression analysis.
RESULTS: 1127 patients were included, with 5.6-year median follow-up. The incidence of clinical anastomotic leak was 3.5%. Sixteen of 677 with defunctioning stoma (2.2%) developed clinical leak; 24 of 450 without stoma (6.3%) developed leak (P = 0.005). There were no perioperative deaths among patients with clinical leakage. When stratified for defunctioning stoma, there was no association between clinical leak and local recurrence, disease-free survival, or overall survival. On multivariable analysis, when controlling for neoadjuvant therapy, distance of tumor from anal verge, defunctioning stoma, and pathologic stage, clinical leak was not associated with time to local recurrence, disease-free survival, or overall survival.
CONCLUSIONS: In this cohort, anastomotic leakage was not associated with risk of local recurrence. Defunctioning stoma was associated with lower incidence of clinical leakage but not with difference in oncologic outcome. Careful patient selection for defunctioning stoma helps reduce risk of clinically significant anastomotic leak.

Entities:  

Mesh:

Year:  2012        PMID: 22584695     DOI: 10.1097/SLA.0b013e318257d2c1

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  30 in total

1.  [Impact of anastomotic leakage on long-term survival in mid-to-low rectal cancer].

Authors:  T Jäger; C Nawara; D Neureiter; J Holzinger; D Öfner-Velano; A Dinnewitzer
Journal:  Chirurg       Date:  2015-11       Impact factor: 0.955

Review 2.  Risk factors and predictive factors for anastomotic leakage after resection for colorectal cancer: reappraisal of the literature.

Authors:  Fumihiko Fujita; Yasuhiro Torashima; Tamotsu Kuroki; Susumu Eguchi
Journal:  Surg Today       Date:  2013-09-05       Impact factor: 2.549

3.  Adipose tissue grafting for management of persistent anastomotic leak after low anterior resection.

Authors:  W J Tan; B J Mehrara; J Garcia-Aguilar; M R Weiser; G M Nash
Journal:  Tech Coloproctol       Date:  2019-10-15       Impact factor: 3.781

Review 4.  Emerging Trends in the Etiology, Prevention, and Treatment of Gastrointestinal Anastomotic Leakage.

Authors:  Sami A Chadi; Abe Fingerhut; Mariana Berho; Steven R DeMeester; James W Fleshman; Neil H Hyman; David A Margolin; Joseph E Martz; Elisabeth C McLemore; Daniela Molena; Martin I Newman; Janice F Rafferty; Bashar Safar; Anthony J Senagore; Oded Zmora; Steven D Wexner
Journal:  J Gastrointest Surg       Date:  2016-09-16       Impact factor: 3.452

5.  Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer.

Authors:  P Sánchez-Velázquez; M Pera; M Jiménez-Toscano; X Mayol; X Rogés; L Lorente; M Iglesias; M Gallén
Journal:  Clin Transl Oncol       Date:  2018-04-05       Impact factor: 3.405

6.  The impact of surgical diversion before neoadjuvant therapy for rectal cancer.

Authors:  Brandon J Anderson; Elizabeth G Hill; Robert E Sweeney; Amy E Wahlquist; David T Marshall; Kevin F Staveley O'Carroll; David J Cole; Ernest Ramsay Camp
Journal:  Am Surg       Date:  2015-05       Impact factor: 0.688

Review 7.  Incidence and mortality of anastomotic dehiscence requiring reoperation after rectal carcinoma resection.

Authors:  Zhi-jie Cong; Liang-hao Hu; Jun-jie Xing; Zheng-qian Bian; Chuan-gang Fu; En-da Yu; Zhao-shen Li; Ming Zhong
Journal:  Int Surg       Date:  2014 Mar-Apr

8.  10-Year Oncologic Outcomes After Laparoscopic or Open Total Mesorectal Excision for Rectal Cancer.

Authors:  Marco E Allaix; Giuseppe Giraudo; Alessia Ferrarese; Alberto Arezzo; Fabrizio Rebecchi; Mario Morino
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

9.  Temporary Diverting Ileostomy via the Umbilicus: a Small Case Series.

Authors:  C D Mushaya; Raaj Chandra; Wendy Sansom; James Keck
Journal:  Int Surg       Date:  2015-03

10.  Double-layered Nanofibrous Patch for Prevention of Anastomotic Leakage and Peritoneal Adhesions, Experimental Study.

Authors:  Jachym Rosendorf; Marketa Klicova; Lenka Cervenkova; Richard Palek; Jana Horakova; Andrea Klapstova; Petr Hosek; Vladimira Moulisova; Lukas Bednar; Vaclav Tegl; Ondrej Brzon; Zbynek Tonar; Vladislav Treska; David Lukas; Vaclav Liska
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.